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Dithiocarbamates are widely used as fungi-
cides because of their efficacy against a
broad spectrum of fungi and their associat-
ed plant diseases. Dithiocarbamates are also
used in industry as slimicides in water-cool-
ing systems, in sugar, pulp, and paper man-
ufacturing, and as vulcanization accelerators
and antioxidants in rubber. Because of their
chelating properties, they are also used as
scavengers in waste-water treatment.
Dithiocarbamates can be divided into
two groups: the ethylenebisdithiocarbamates
(EBDC), such as maneb, zineb, and man-
cozeb, and the dimethyldithiocarbamates
(DMDC), including ferbam, ziram, and thi-
ram. In recent years there has been increas-
ing awareness of the hazards of various syn-
thetic organic chemicals to living organisms.
Ethylenethiourea (ETU) is one of the
principal metabolites of EBDCs and is
thought to be the source of most of the
toxicity associated with EBDCs. ETU is a
degradation by-product of the manufacture
of EBDCs (in tobacco, cooked foods, com-
mercial beverages, etc.), formed during
product storage (1-4). ETU is also the
major identifiable product of ultraviolet
irradiation, according to Gruiskshan and
Jarrow, who studied its photolysis and
hydrolysis (5). EBDCs are metabolized by
mammals to ETU (6,7). Extensive methy-
lation of ETU occurs in the cat, but not
the rat (8). Although no studies of ETU
formation have been conducted in
humans, ETU has been found in the urine
of potato farmers exposed to EBDCs (9),
implying that such metabolism occurs.
Because ETU can be produced by
hydrolytic thermal decomposition of
EBDCs, it is difficult to analyze. Several
rather cumbersome techniques that have
been used and the best currently available
technique are reviewed below (10-13).
Even though the acute toxicity of pure
EBDCs is low, the health of workers may
be jeopardized by inhaling ETU or EBDCs
(14). ETU is hydrosoluble and has raised
concern because of its thyroid toxicity and
tumorigenicity (15-18). In this review, we
summarize and analyze the available data
on EBDCs used as pesticides to indicate
their impact on mammals.
Presence ofETU in Commercial
Food Products
Several foods purchased locally were found
to contain small quantities of ETU (10,19).
Pease and Holt (20) reported that tomatoes
(including tomato juice, soup, canned
tomatoes, and catsup), potatoes, cucumbers,
summer squash, and cantaloupes taken from
17 different locations throughout the
United States where maneb was applied
according to label directions showed no
residue of ETU (<0.05 ppm), even in the
presence of 4 ppm of maneb (1 day after the
last of three applications on tomatoes).
Wine contained 0.037 ppm ETU and
no residue of EBDC. ETU residues in beer
ranged from 0.026 to 0.07 ppm (21).
Studies with [ 4C]ETU show that more
than 80% of the applied dose remained in
the beer after fermentation (19).
ETU is produced by burning cigarettes,
at a quantity of about 50% of the EBDC
residue in the tobacco (determined by mea-
surement of carbon disulfide). For instance,
32 ppm of EBDC in tobacco produced
about 16 pg ETU/g, of which one-tenth
was absorbed by the smokers (19). Such
direct absorption by smokers, and absorp-
tion by nonsmokers through passive smok-
ing, along with absorption from consump-
tion of cooked vegetables containing
EBDC residues, may be the most impor-
tant source of exposure to ETU among the
general public (19,22).
Kinetics and Metabolism
In general, dithiocarbamates can be
absorbed via the skin, the mucous mem-
branes, and the respiratory and gastroin-
testinal (GI) tracts. Whereas dithiocarba-
mates are absorbed rapidly from the GI
tract, metal-complexed alkylene bisdithio-
carbamates are absorbed poorly from both
the GI tract and through the skin (23).
ETU is rapidly absorbed from the GI
tract and cleared from the body in all mam-
malian species that have been tested. After
only 5 min, ETU appeared in the blood of
rats administered an oral dose of 100 mg/kg
body weight of [4C]ETU. Within 48 hr,
82-99% of an oral dose was eliminated via
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the urine and about 3% via the feces
(24,25). Newsome (6) and Ruddick et al.
(26) found that approximately 70% of
ETU was eliminated in the urine and 1%
in the feces; comparable results were found
for mice, while in monkeys 55% was elimi-
nated via the urine within 48 hr and less
than 1.5% via the feces (27).
ETU and its metabolites have a half-life
of about 28 hr in monkeys, 9-10 hr in rats,
and 5 hr in mice (25). In a study of the
accumulation and elimination of radioac-
tivity by the thyroid gland of rats dosed
with ETU, dose levels of 2 and 200 pg
14C-labeled ETU were administered daily
for 14 days (28). In a second experiment
rats were dosed with 0, 0.1, 1, 10, 50, or
100 mg [l C]ETU/kg body weight in food
daily for 7 days (28). The first experiment
showed that the concentration of ETU
and/or its metabolites in the thyroid is dose
dependent, and the second experiment
showed that the level of l C in the thyroid
did not increase appreciably when the daily
dose was increased above 50 mg/kg diet.
Withdrawal ofETU from the diet led to an
80-94% reduction in the radioactivity in
the thyroid after 17 days (28).
In a recent study conducted in potato
growers, ETU, used as a biological indica-
tor ofEBDC exposure, had a long half-life
(32-100 hr) and could therefore be detect-
ed in urine even several days after exposure
(9). Other investigators (29) reported that
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in a sample of 10 farmers exposed to
dithiocarbamate, monitored thoughout the
entire exposure period (approximately 5
hr), ETU was identifiable in urine samples
collected immediately after exposure in
only three, and persistence of ETU in
urine over the entire 40-hr period after
exposure was observed in only one subject.
However, Kurttio and Savolainen (9)
reported an elimination half-life for ETU
of close to 100 hr in 38 potato farmers
exposed to EBDCs.
The metabolic decomposition of
EBDCs in mammals is complex and results
in the formation of carbon disulfide, ethyl-
ene diamine, a few ethylene bisthiuram
disulfides, ethylene bisthiocyanate, hydro-
gen sulfide, and ETU. Dithiocarbamates
and their metabolic products are found in
certain organs, such as the liver, kidneys,
and especially the thyroid, but accumula-
tion of these compounds does not take place
because of their rapid metabolism (23).
With regard to the hepatic metabolic
system, liver monooxygenases in rats are
inhibited by oral administration of ETU
(30). In mice, however, these same
researchers found opposite effects: ETU
treatment caused an increase in cytochrome
P450 content and aniline hydroxylase activ-
ity. In addition, a dose 20 times that pro-
ducing inhibition of aminopyrine N-
demethylase activity in rats had no effect on
this enzyme in liver microsomes of mice.
Lewerenz and Plass (31) suggested that
the different response of hepatic microso-
mal enzymes may contribute to the differ-
ence in acute toxicity and teratogenicity
between mice and rats. This implies that
ETU is likely metabolized by different
enzymatic pathways. Compounds identi-
fied after oral administration of ETU in
the urine of mice were 2-imidazolin-2-yl-
sulfenate, ethylene urea, and unchanged
ETU (32-34). The S-oxidation of ETU
occured in the microsomal fraction of
mouse liver (32). Imidazole, ethylene urea,
imidazolone, and unchanged ETU were
detected in the urine of rats (8).
Hui (35) noted that although flavin-
dependent monooxygenase metabolism
and binding is a major pathway for ETU
biotransformation in the mouse, the toxi-
cological significance of this fact is not
clear. Siddiqui et al. (36) comparatively
evaluated the acute effects of the EBDC
fungicides mancozeb and zineb on micro-
somal mixed-function oxidase (MFO) in
male albino rats. The differences in the
inhibitory effectiveness of mancozeb and
zineb toward MFO may be attributed to
the presence of both Mn2+ and Zn2+ in
mancozeb and zineb molecules, differences
in their absorption and disposition kinet-
ics, and/or in their metabolic products. In
addition, the tendency of these fungicides
to chelate metal-containing enzymes such
as cytochromes (37) appears to be another
likely mechanism of their toxicity. Mn2+
(38) and Zn2+ (39) have been shown to
elicit a significant inhibition of hepatic
microsomal hydroxylation of aniline and
N-demethylation of aminopyrine. It has
been suggested that this inhibition of
monooxygenase occurs as a result of denat-
uration of cytochrome P450 brought
about by an interaction of EBDC with the
sulfhydryl groups of cytochrome P450 and
by some other unknown mechanism, prob-
ably related to its lipophilic character.
Analytical Methods
Since EBDC tolerances for zineb were first
established in 1955, the official methodol-
ogy used by the U.S. Food and Drug
Administration (FDA) for analyzing
EBDC residues on food has been a non-
specific method based on the colorimetric
determination of a yellow complex formed
by reaction of evolved carbon disulfide
(CS2) with a reagent after acid hydrolysis
of the sample (40). Because this method
cannot distinguish between residues of
individual EBDCs, all EBDC tolerances
are based on zineb.
A further limitation of this method is
that it cannot distinguish EBDC residues
from those of another major subgroup of
dithiocarbamate fungicides, the
dimethyldithiocarbamates (ferbam and
ziram). Today, refinements of this basic
methodology can separate and measure
residues of individual EBDCs on crops.
The analytical methodology for ETU
has been more actively developed because
of concern about its presence in food. The
FDA methodology for residues does not
detect ETU, since ETU cannot evolve
CS2. However, several reports have
described analytical methods for ETU
(1,2,12,41-46).
Gas chromatography is still the major
technique for the residue analysis of ETU,
using precolumn derivatization to achieve
sensitivity and specificity (2,6,47,48).
Under suitable clean-up and GC condi-
tions, the procedures allow a detection
limit of 10 ppb in various foodstuffs. The
derivatization procedures are, however,
time consuming, and additional ETU may
be formed during reactions at elevated
temperatures as a result of decomposition
ofEBDC residue present in the sample.
Column liquid chromatography (LC)
has also been applied using either nonselec-
tive UV absorbance detection with a rather
complicated sample clean-up (11,49), or
selective electrochemical detection, for
which sample clean-up is much simpler
(46,50,51). This method can be done with
much simpler sample clean-up. In fact, for
determination of ETU in wine and beer,
down to a level of about 50 ppb, no clean-
up is necessary at all (52).
These GC and LC methods share the
disadvantages of laboriousness and/or
insufficient sensitivity. Hogendoorn et al.
(13) therefore investigated the potential of
reverse-phase LC column switching for
trace-level determination of ETU in water
samples. They found that column switch-
ing was adequate for the clean-up and con-
centration of chloroallylalcohol (CAAL)
from aqueous samples, even in combina-
tion with relatively nonselective detection
(UVW 205 nm). Because ETU is consider-
ably more polar than CAAL and is conse-
quently even less retained on a C18 col-
umn, development of a reverse-phase col-
umn switching procedure is inherently
more difficult. This study reports such a
development for the trace-level determina-
tion of ETU in ground waste samples
down to about 0.05 ppb.
Other analytical methods of determin-
ing ETU have also been reported, includ-
ing thin-layer chromatography (TLC),
polarography, and radioisotope dilution. A
variety of absorbents and developing sol-
vents (TLC) have been used to detect ETU
in plants (1,12,53,43). Semi-quantitative
determinations are possible by comparison
with ETU standards run simultaneously
(54). Polarography involves clean-up on an
alumina column, followed by paper chro-
matography and determination of the
nitroso derivative by polarography (1).
Radioisotope dilution, a reverse isotope
dilution method, has been used to deter-
mine ETU in the presence of its metabo-
lites and is useful in the low milligram
range (41,54)
Animal Studies
ETU generally has low acute toxicity, but
it does induce a wide spectrum of anom-
alies in many test animals fed significant
doses for various lengths of time. The most
prominent aspect of ETU toxicology is its
action on the thyroid gland, with resultant
hyperplasia and decrease in thyroid hor-
mone levels. ETU has also been shown to
have teratogenic, carcinogenic, immuno-
toxic, and mutagenic effects in various ani-
mals studies (55-58).
Carcinogenicity. Several studies have
shown that the prolonged administration
of ETU to rats causes thyroid neoplasms
(17,41,56,59-61). Ulland (17) included
350 and 175 ppm ETU in the diet of male
and female rats, which led to a dose-related
induction of follicular and papillary thy-
roid cancers, and of related lesions such as
thyroid solid-cell adenomas and hyperplas-
tic and simple goiter. The first tumor was
found after 68 weeks, and most cancers
occurred after 18-24 months, when the
study was terminated.
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Recently Chhabra et al. (61) studied
the perinatal and adult exposure of ETU
induction of thyroid neoplasms in rats and
identified similar thyroid effects in mice.
They confirmed that ETU was carcino-
genic in both male and female rats at
dietary concentrations of 83 and 250 ppm,
regardless of the level of perinatal exposure.
Males were more sensitive than females, as
demonstrated by a higher incidence of fol-
licular cell neoplasms (adenoma or adeno-
carcinoma).
The possible mechanism of thyroid fol-
licular cell carcinogenesis in rodents has
been reviewed recently (62-65). Exposure
to ETU, for either 9 months or 2 years, led
to a general decrease in serum T4 levels
and increase in serum thyroid-stimulating
hormone levels in both rats and mice.
These hormonal changes correlated with
morphological changes in the thyroid
glands, suggesting that ETU carcinogenesis
may be due to an imbalance of thyroid-
pituitary homeostasis.
Chronic ETU administration produces
hepatocellular carcinoma in the mouse and
rat (16,56,61). Innes (16) reported induc-
tion of liver neoplasms in mice exposed to
dietary concentrations of 646 ppm ETU
for 18 months. Two strains of mice fed
ETU in the diet had an increased inci-
dence of hepatomas (56). Centrilobular
hepatocellular cytomegaly occurred in male
and female mice and rats receiving ETU at
concentrations of 500 ppm or greater.
Hepatocytes surrounding the central
venules were enlarged, with homogeneous-
ly staining, finely granular eosinophilic
cytoplasm (61).
Thus, toxicological studies have gener-
ally shown that although the thyroid is the
major site of ETU-induced carcinogenici-
ty in rats (17,59,60), the liver is also a
major target of ETU-induced carcino-
genicity in mice (16).
While the incidence of neoplasms and
non-neoplastic lesions after exposure to
EBDCs or ETU is only clearly proven to
be increased in the thyroid gland or liver,
several isolated studies suggest a possible
effect on other sites as well. Chhabra et al.
(61) showed statiscally significant increases
in neoplasms of the Zymbal gland and of
the hematopoietic system in ETU-treated
rats, as compared to control animals. There
was also a statistically insignificant trend
toward a slight increase in rare renal tubu-
lar cell neoplasms. In addition, Chernov
and Khistenko (66) and Balin (67) have
reported that zineb and maneb induced
pulmonary adenomas in mice after oral
administration. Finally, Ulland et al. (17)
described pulmonary metastases in rats
with oral exposures.
Mutagenicity. With regard to the
mutagenicity of EBDC, Seiler (68) found
that maneb was negative in tests with
Salmonella strains HisG46, TA1530,
TA1531, and TA1532, and doubtful in
TA1534. In addition, maneb and zineb
given intraperitoneally to mice at 100
mg/kg body weight caused chromatid
aberrations in bone marrow cells (55,69).
For ETU, tests with a large number of
S. typhimurium strains gave mostly nega-
tive results (70,71). However Seiler (72)
reported weak (dose unrelated) mutagenic-
ity in S. typhimurium strain G46. ETU was
also mutagenic in a host-mediated assay of
S. typhimurium TA1530, when mice were
dosed with 6000 mg ETU/kg body weight,
but not at doses of 2000 mg/kg or less
(73). Schupbach and Hummler (73,74)
also reported that ETU appeared to induce
base-pair mutations but not frameshift
mutations in S. typhimurium TA98, TA
1537, and TA1538 exposed to ETU in the
presence of dimethysulfoxide and/or liver
microsomes (25).
Teratogenicity. EBDCs are teratogenic
in rats, mice, and hamsters, but not in cats.
In rats, the major reproduction indices
were unaffected by maneb dietary levels of
< 250 mg/kg diet. There was no histologi-
cal evidence of congenital anomalies in a
variety of tissues and organs of male and
female rats of the F3b litter subjected to
histopathological examination (75).
Maneb, zineb, and mancozeb exert dose-
dependent damaging effects on the gonads
of rats of both sexes. The dose levels used
were 96-960 mg/kg body weight of zineb,
140-1400 mg/kg of mancozeb, and
14-700 mg/kg of maneb, each given twice
a week for 4.5 months. Both reproductive
and endocrine structures were affected at
all dose levels, leading to decreased fertility
(76,77). In a 4-month inhalation study on
rats using maneb at 4.7 mg/m3, no effect
on sperm motility was detected (78).
Administration of 100 mg/kg body weight
of zineb to rats for a period of 2, 4, or 6
months produced delayed insemination,
sterility, resorption of fetuses, and develop-
mental anomalies (79).
In both rats and hamsters exposed to
EBDCs, malformations of the brain pre-
dominate (80,81). The major teratologic
effect is the development of hydrocephalus
and other central nervous system defects
postnatally, resulting in a high mortality
rate among the offspring (56). In studies
by Larsson et al. (82), maneb was adminis-
tered to Sprague-Dawley rats at dose levels
of 0, 400, 770, or 1420 mg/kg body
weight, by gavage, as a single dose on day
11 of gestation. Gross malformations
occurred in all surviving animals at 770
and 1420 mg/kg, but no malformations
were observed in the single litter of the
low-dose group. CDI mice administered 0,
375, 750, or 1500 mg maneb/kg body
weight on days 7-16 of gestation showed a
decrease in fetal caudal ossification centers
at all dose levels (83). Abnormalities
included cleft palate, hydrocephalus, and
other serious defects. Abnormalities found
at the highest dose level may have been due
in part to the presence of ETU in the for-
mulation (84).
In contrast to these findings in other
species, teratogenicity has not been
observed in cats given daily doses of 0, 5,
10, 30, 60, or 120 mg ETU/kg (85). The
explanation for this exception is not cer-
tain, but it may be that extensive methyla-
tion of ETU occurs in the cat, but not the
rat (8).
Human Studies
The acute toxicity of dithiocarbamates is
low, and acute intoxication in human
beings is therefore unlikely. There is a
report, however, of a 62-year-old man who
developed acute renal insufficiency after
applying maneb. A causal relationship of
the exposure is not clear, however, because
the patient had a history of hypertension,
cerebral infarction, and gastrectomy and
chemotherapy (for stomach cancer). The
patient was treated with hemodialysis and
survived to hospital discharge (86).
Temporary alterations in central nervous
functions (87), diarrhea, and acute renal
and transient heart failure (86) have also
been reported after acute exposure to
EBDCs.
In numerous studies EBDCs and ETU
have been strong skin sensitizers (88-93).
The irritant and allergic potential of most
dithiocarbamates is evident upon occupa-
tional exposure.
Cases of diffuse erythema and eczema-
toid epidermatitis of the eyelids and
inguinal regions, probably with elements of
sun sensitization, were observed among
agricultural workers (grapes and tobacco) in
contact with zineb (94) or maneb (95-98).
In a rarely cited epidemiologic study,
which is the only such study currently
available, von Meyer (99) found trends
toward increasing incidences of human
liver and thyroid cancers in several geo-
graphic areas of the United States, in rela-
tion to the degree of exposure to dithiocar-
bamates, as determined by sales and crop
production statistics for dithiocarbamate-
containing pesticides. The study was con-
ducted in four states (New York, Florida,
Maine, and Pennsylvania), with an overall
sample size of more than 27 million people
in the countries surveyed. In comparison
to very low baseline national incidences of
these cancers, the slight increases in the
exposed communities (over a 20-year peri-
od, following introduction of widespread
agriculture use of these pesticides) were for
the most part not statistically significant.
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In 1978, Lybarger (100), in a study of
workers at a plant that produces ETU in
the United States, found only slight differ-
ences in levels of T4 and T3 in 43 workers
and 7 controls subjects. Smith (101) carried
out a study of thyroid function which was
somewhat limited by the small number of
workers and by the intermittent nature of
the mixing work. He found no evidence
that thyroid function is severely affected by
exposure to ETU at the levels experienced
by these workers, nor was there evidence of
any clinical effect. Only one worker was
considered hypothyroid upon biological
testing, although T4 results in the exposed
workers were generally somewhat lower
than those in control subjects.
A Parkinsonian syndrome has also been
reported in two young, previously healthy
agricultural workers after chronic exposure
to maneb (102). Subsequent evaluation of
50 other workers similarly exposed on a
chronic basis found significantly increased
incidences of various neurologic effects
(including cogwheel rigidity, fatigue, and
complaints of memory loss) and increases
in a variety of other Parkinson-like symp-
toms (including tremor, ataxia, and
bradykinesia) compared to a control group
of workers not exposed to this pesticide.
Although such toxic effects are probably
attributable to the manganese contained in
this pesticide, the possibility of an inde-
pendent contribution of the EBDC itself
cannot be entirely eliminated.
Discussion
Human exposure to EBDCs, and the toxic
EBDC metabolize ETU, is not insignifi-
cant. Although these compounds affect
primarily workers in specific industries,
ETU is also present in relatively small
quantities in a number of common food-
stuffs. It is therefore important to analyze
the risks incurred by such exposures, par-
ticularly in light of the known toxicities of
these chemicals in animals.
The toxicokinetics of EBDCs have
been well studied. EBDCs are absorbed
slowly through the GI tract and skin and
are metabolized via hepatic microsomal
enzymes to produce ETU, which appears
to be the major cause of toxicity of these
chemicals. ETU is rapidly absorbed via the
GI tract (23). The elimination of ETU is
largely renal (27), and its elimination half-
life is variable, ranging between 32-100 hr,
according to the species involved (9,25).
EBDC residues accumulate preferentially
in the thyroid, and secondarily in the liver
(28).
Differences in acute toxicity as well as
in teratogenicity are seen in mice and rats
exposed to ETU directly. In addition, ter-
atogenicity does not occur in the cat,
which unlike other species extensively
metabolizes ETU to its S-methyl deriva-
tive. Thus, interspecies differences in
hepatic microsomal enzyme activity,
regarding both the formation ofETU from
EBDCs and its subsequent transformation,
are most likely responsible for the variable
toxicity in different species (8,31-33).
Since these same metabolic pathways for
EBDC and ETU may also be different in
humans, there may also be major differ-
ences in the toxicity of EBDCs in humans,
in ways that cannot be easily predicted.
It is possible today to chemically evalu-
ate the presence ofEBDCs and ETU with a
fairly high degree of accuracy. Although
many methods initially proposed in the lit-
erature are neither adequately sensitive or
specific, a method described by Hogendorn
in 1991 (13), based on a reverse-phase LC
column-switching technique, has proven to
be quite specific and sensitive enough to
allow detection of residual quantities on the
order of parts per trillion.
It is clear that EBDCs and ETU are
potentially toxic in chronically exposed
animals. Although it remains difficult to
evaluate the effects of acute intoxications
with these agents because only a few stud-
ies of such toxicity have been done, the
toxicity of prolonged exposures is defini-
tive. Adverse effects include a variety of
acute symptoms, as well as evidence of
carcinogenesis, mutagenesis, and teratoge-
nesis. Although several authors have
described adverse effects on the liver
(16,56,61), and one investigator has actu-
ally stated that the liver is the primary tar-
get organ (60), the bulk of evidence sug-
gests that it is in fact the thyroid which is
most adversely affected by these chemicals
(17,41,56,59-61). Thyroid and hepatic
neoplasms both occur in animals exposed
to EBDCs and ETU, but the teratogenici-
ty ofETU appears to be limited to rats and
hamsters (8,26,33,71,80), among species
thus far studied. The major target organ of
this teratogenicity, it is generally agreed, is
the brain (56,80,81).
Since the different toxic response seen
among various animal species is best
explained by differences in their metabo-
lism of EBDCs, such that one cannot easi-
ly extrapolate these findings directly to
humans, and since few studies of exposure
to EBDCs have been conducted in
humans, our current knowledge of the
subject must be considered quite limited.
Nevertheless, there is enough evidence to
conclude that these chemicals exert at least
some toxic effect, the maximum degree of
which is not yet certain.
EBDCs and ETU definitely have an
irritant effect on human skin (88-93), but
information regarding more important
types of toxicity is inconclusive. With
regard to pathologic changes in the thyroid
and the liver, no direct relation has been
established vis-a-vis exposure to EBDCs,
although one large epidemiologic study
may suggest a possible relationship
between use of dithiocarbamates and
human liver and thyroid cancers. In this
study there were statistically insignificant
trends toward increased incidence of these
neoplasms in four geographic areas of the
United States where dithiocarbamate-con-
tamning pesticides are most commonly
used, as evidenced by sales and crop pro-
duction statistics (99). Although von
Meyer downplays the significance of the
small differences noted, it remains possible
that excess cancer rates were not proven
statistically only because of insufficient
power of the study, despite its size and 20-
year duration. In the presence of extremely
low baseline rates of these cancers in the
general community, and given the diluting
effect of surveillance of all individuals in a
geographic area, including many who are
not exposed to the putative causative
agent, it would require enormous sample
sizes to find even relative increases in can-
cer incidence. Because no other studies
have been done on the subject, the ques-
tion of possible carcinogenicity of EBDCs
in humans remains unanswered.
Conclusions
Humans are exposed to EBDCs, especially
certain classes of workers for whom this
exposure is chronic. Such EBDCs, and
particularly the EBDC metabolite ETU,
have clear and important toxic effects in
various animal species, and there is reason
to at least suspect possible carcinogenicity
of these agents in humans. It is therefore
desirable that further human studies be
done to better define and assess this risk.
Such research is feasible today, in light of
available methods to quantitate degrees of
exposure to these chemicals. Furthermore,
pending the results of such studies, it
would clearly be desirable to undertake
regular surveillance of humans exposed to
EBDCs, with specific attention to markers
of thyroid and hepatic pathology.
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